Veteran growth-oriented private equity investor and board director, Michael Bosman, focuses on scaling mid-market technology and healthcare companies across Europe. He combines prior operating experience with deal origination, value creation planning and exit execution. Known for hands-on portfolio governance and operational restructuring, he has led buyouts, minority growth investments and strategic carve-outs. Background in finance and corporate strategy supports capital raising and investor relations.
Veteran growth-oriented private equity investor and board director, Michael Bosman, focuses on scaling mid-market technology and healthcare companies across Europe. He combines prior operating experience with deal origination, value creation planning and exit execution. Known for hands-on portfolio governance and operational restructuring, he has led buyouts, minority growth investments and strategic carve-outs. Background in finance and corporate strategy supports capital raising and investor relations.
Growth-focused private equity approach centered on scaling mid-market technology and healthcare firms across Europe. Prefers control or influential minority positions where operational playbooks, restructuring and go-to-market expansion unlock revenue and margin upside. Allocates capital with a 3–7 year value-creation horizon, blending buyouts, carve-outs and follow-on growth funding. Underwrites deals with financial rigor and operational KPIs, prioritizing strong management alignment, disciplined leverage and clear exit pathways via strategic sale or IPO. Active board involvement and hands-on governance drive execution risk mitigation and accelerated operational improvement.
Growth-focused private equity approach centered on scaling mid-market technology and healthcare firms across Europe. Prefers control or influential minority positions where operational playbooks, restructuring and go-to-market expansion unlock revenue and margin upside. Allocates capital with a 3–7 year value-creation horizon, blending buyouts, carve-outs and follow-on growth funding. Underwrites deals with financial rigor and operational KPIs, prioritizing strong management alignment, disciplined leverage and clear exit pathways via strategic sale or IPO. Active board involvement and hands-on governance drive execution risk mitigation and accelerated operational improvement.
| Trades 245 | Longs Won 129/245 52% | Profit Factor 4.36 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $909,217.21 |
| Average Win $479,468.69 | Best Trade (Jul 14) $10.8M | Sharpe Ratio -237.97 |
| Average Loss -$122,372.69 | Worst Trade (Jul 14) -$1.39M | Z-Score -1.88 (96.22%) |
| Commissions $0 | Avg. Trade Length 7m 3w 1d | Expectancy $194,515.22 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.11% |
| Consecutive Losing Trades | 1,134 | 1,020 | 907 | 794 | 680 | 567 | 454 | 340 | 227 | 113 |